Home LiteratureArticle Details
PMID: 19741235 Published · ppublish English Letter Comment

Mutation in TET2 in myeloid cancers.

The New England journal of medicine ·Vol. 361 ·No. 11 ·2009-09-10 ·Pages 1117; author reply 1117-8

Tefferi A, Lim KH, Levine R

Abstract

暂无摘要

MeSH Terms
DNA-Binding Proteins/genetics Dioxygenases Disease Progression Genes, Tumor Suppressor Humans Leukemia, Myeloid/genetics Mutation Myelodysplastic Syndromes/genetics Myeloproliferative Disorders/genetics Proto-Oncogene Proteins/genetics
Chemicals
DNA-Binding Proteins Proto-Oncogene Proteins Dioxygenases TET2 protein, human
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tefferi Ayalew
Lim Ken-Hong
Levine Ross
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMc091348
Published
2009-09-10
Pages
1117; author reply 1117-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 19474426
External Links
PubMed source DOI: 10.1056/NEJMc091348 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2